← The Wire
MLYSNasdaq
Mineralys Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1933414
Developing medicines targeting diseases driven by dysregulated aldosterone, including hypertension and related conditions
$2.08B
Market cap
$26.88
Last close
+0.8%
1D
+6.0%
5D
1.6M
Volume
Price · last 39 sessions-9.3%
May 4L $22.50 · H $31.54Jun 29
81
Total filings
Jun 3, 2026
Last filing
12/31
Fiscal year end
8-KCompany UpdateJun 3, 2026424B5424B5Jun 3, 20268-KMaterial Agreement · New Debt / ObligationJun 3, 20268-KShareholder VoteMay 22, 202610-Q10-QMay 6, 20268-KResults of OperationsMay 6, 2026DEFA14ADEFA14AApr 8, 2026DEF 14ADEF 14AApr 8, 202610-K10-KMar 12, 20268-KResults of OperationsMar 12, 20268-KReg FD Disclosure · Company UpdateMar 9, 20268-KReg FD Disclosure · Company UpdateJan 6, 202610-Q10-QNov 10, 20258-KResults of OperationsNov 10, 20258-KCompany UpdateSep 3, 2025424B5424B5Sep 3, 20258-KCompany UpdateSep 2, 2025424B5424B5Sep 2, 202510-Q10-QAug 12, 20258-KResults of OperationsAug 12, 20258-KReg FD Disclosure · Company UpdateJun 17, 20258-KShareholder VoteMay 22, 202510-Q10-QMay 12, 20258-KResults of OperationsMay 12, 2025DEFA14ADEFA14AApr 9, 2025DEF 14ADEF 14AApr 9, 20258-KReg FD Disclosure · Company UpdateMar 31, 20258-KCompany UpdateMar 12, 2025424B5424B5Mar 12, 2025424B5424B5Mar 10, 20258-KReg FD Disclosure · Company UpdateMar 10, 202510-K10-KFeb 12, 20258-KResults of OperationsFeb 12, 20258-KReg FD Disclosure · Company UpdateFeb 4, 20258-KReg FD Disclosure · Company UpdateJan 8, 202510-Q10-QNov 12, 20248-KResults of OperationsNov 12, 20248-KReg FD Disclosure · Company UpdateOct 30, 20248-KReg FD Disclosure · Company UpdateSep 25, 202410-Q10-QAug 13, 20248-KResults of OperationsAug 13, 20248-KExecutive ChangeJun 14, 20248-KCompany UpdateJun 10, 20248-KCompany UpdateMay 31, 20248-KShareholder VoteMay 22, 202410-Q10-QMay 9, 20248-KResults of OperationsMay 9, 2024424B5424B5Apr 11, 2024DEFA14ADEFA14AApr 9, 2024DEF 14ADEF 14AApr 9, 20248-KExecutive ChangeApr 4, 20248-KMaterial Agreement · Results of OperationsMar 21, 202410-K10-KMar 21, 2024SC 13GSC 13GFeb 15, 2024SC 13GSC 13GFeb 14, 2024SC 13GSC 13GFeb 13, 2024SC 13GSC 13GFeb 13, 20248-KMaterial Agreement · Equity IssuanceFeb 8, 20248-KExecutive Change · Reg FD DisclosureJan 4, 20248-KReg FD Disclosure · Company UpdateDec 22, 20238-KReg FD Disclosure · Company UpdateNov 13, 202310-Q10-QNov 7, 20238-KResults of OperationsNov 7, 20238-KReg FD DisclosureNov 2, 20238-KExecutive ChangeSep 14, 202310-Q10-QAug 7, 20238-KResults of OperationsAug 7, 20238-KReg FD DisclosureJul 17, 202310-Q10-QMay 15, 20238-KResults of OperationsMay 15, 20238-KCompany UpdateMay 2, 20238-KExecutive ChangeMar 22, 202310-K10-KMar 15, 20238-KResults of OperationsMar 15, 2023SC 13DSC 13DFeb 24, 2023SC 13GSC 13GFeb 24, 2023SC 13DSC 13DFeb 24, 20238-KBylaw Amendment · Company UpdateFeb 14, 2023424B4424B4Feb 10, 2023S-1/AS-1/AFeb 2, 2023
Insider Activity
In the 90 days to Mar 30, 2026: 1 insider bought $8.8M · 3 sold $12.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 30, 2026 | Shah Rajeev M.Director | Buy | 58,300 | $24.16 | $1.4M |
| Mar 27, 2026 | Shah Rajeev M.Director | Buy | 310,700 | $23.67 | $7.4M |
| Mar 17, 2026 | Rodman David MalcomChief Medical Officer | Sell | 417 | $25.65 | $11K |
| Mar 13, 2026 | Rodman David MalcomChief Medical Officer | Sell | 10,726 | $25.91 | $278K |
| Mar 13, 2026 | Rodman David MalcomChief Medical Officer | Sell | 3,079 | $27.37 | $84K |
| Mar 13, 2026 | Rodman David MalcomChief Medical Officer | Sell | 253 | $27.82 | $7K |
| Mar 12, 2026 | Rodman David MalcomChief Medical Officer | Sell | 6,348 | $27.37 | $174K |
| Mar 9, 2026 | Rodman David MalcomChief Medical Officer | Sell | 2,171 | $26.84 | $58K |
| Feb 17, 2026 | Rodman David MalcomChief Medical Officer | Sell | 417 | $27.59 | $12K |
| Feb 13, 2026 | Rodman David MalcomChief Medical Officer | Sell | 6,348 | $27.58 | $175K |
| Feb 13, 2026 | Rodman David MalcomChief Medical Officer | Sell | 4,166 | $27.33 | $114K |
| Feb 13, 2026 | Rodman David MalcomChief Medical Officer | Sell | 3,541 | $27.33 | $97K |
| Feb 12, 2026 | Rodman David MalcomChief Medical Officer | Sell | 5,828 | $28.94 | $169K |
| Feb 12, 2026 | Rodman David MalcomChief Medical Officer | Sell | 521 | $29.64 | $15K |
| Feb 9, 2026 | Rodman David MalcomChief Medical Officer | Sell | 2,171 | $30.21 | $66K |
| Jan 20, 2026 | Rodman David MalcomChief Medical Officer | Sell | 416 | $32.10 | $13K |
| Jan 14, 2026 | Rodman David MalcomChief Medical Officer | Sell | 11,367 | $32.61 | $371K |
| Jan 13, 2026 | Rodman David MalcomChief Medical Officer | Sell | 7,709 | $32.75 | $252K |
| Jan 12, 2026 | Levy Adam ScottCFO and Secretary | Sell | 10,758 | $32.14 | $346K |
| Jan 12, 2026 | Congleton JonChief Executive Officer | Sell | 9,119 | $32.21 | $294K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance